文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症流感与COVID-19患者肺部细菌谱及曲霉病比较

Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01
一句话结论重症流感患者肺部曲霉检出率高于细菌病原体,细菌病原体检出与不良预后相关,尤其在流感相关肺曲霉病患者中。

该回顾性研究纳入机械通气的流感与COVID-19患者,比较肺部细菌微生物组与曲霉感染的关系。流感患者中细菌病原体检出率为20%(28/142),COVID-19患者为37%(104/281);曲霉病在流感患者中检出率为38%(54/142),COVID-19患者为31%(86/281)。细菌病原体与90天死亡率的相关性仅在流感患者中显著,尤其在流感相关肺曲霉病患者中;COVID-19患者对细菌病原体表现出升高的促炎性肺部细胞因子反应。结论提示曲霉在重症流感患者肺部比细菌病原体更常见,细菌病原体检出与流感患者不良预后相关。

要点

  • 重症流感患者肺部曲霉病检出率38%(54/142),高于细菌病原体检出率20%(28/142)。
  • COVID-19患者细菌病原体检出率37%(104/281),曲霉病检出率31%(86/281)。
  • 细菌病原体与90天死亡率的相关性仅在流感患者中显著,尤其在流感相关肺曲霉病患者中。
  • COVID-19患者对细菌病原体表现出升高的促炎性肺部细胞因子反应,流感患者未见此现象。
  • 作者认为三重病毒-真菌-细菌相互作用的免疫动力学值得进一步研究。

适用人群与场景

  • 机械通气的流感与COVID-19患者,有或无侵袭性曲霉病,在ICU入院后2周内获取支气管肺泡灌洗液进行细菌培养(伴或不伴PCR)。
  • 部分患者还分析了16S rRNA基因测序数据及支气管肺泡灌洗液病毒和细菌载量,包括需要无创通气的患者。

研究设计与关键结果

  • 回顾性研究:机械通气的流感与COVID-19患者,有或无侵袭性曲霉病。
  • 流感患者中潜在细菌病原体检出率20%(28/142),COVID-19患者37%(104/281)。
  • 流感患者中曲霉病检出率38%(54/142),COVID-19患者31%(86/281)。
  • 细菌病原体与90天死亡率的相关性仅在流感患者中显著,尤其在流感相关肺曲霉病患者中。
  • COVID-19患者(而非流感患者)对细菌病原体表现出升高的促炎性肺部细胞因子反应。

证据类型、等级与局限

  • 证据类型:回顾性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为三重病毒-真菌-细菌相互作用的免疫动力学值得进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA) has yet to be explored. Objectives: To explore the composition of the lung bacterial microbiome and its association with viral and fungal infection, immunity, and outcome in severe influenza versus COVID-19 with or without aspergillosis. Methods: We performed a retrospective study in mechanically ventilated patients with influenza and COVID-19 with or without invasive aspergillosis in whom BAL for bacterial culture (with or without PCR) was obtained within 2 weeks after ICU admission. In addition, 16S rRNA gene sequencing data and viral and bacterial load of BAL samples from a subset of these patients, and of patients requiring noninvasive ventilation, were analyzed. We integrated 16S rRNA gene sequencing data with existing immune parameter datasets. Measurements and Main Results: Potential bacterial pathogens were detected in 20% (28/142) of patients with influenza and 37% (104/281) of patients with COVID-19, whereas aspergillosis was detected in 38% (54/142) of patients with influenza and 31% (86/281) of patients with COVID-19. A significant association between bacterial pathogens in BAL fluid and 90-day mortality was found only in patients with influenza, particularly patients with IAPA. Patients with COVID-19, but not patients with influenza, showed increased proinflammatory pulmonary cytokine responses to bacterial pathogens. Conclusions: Aspergillosis is more frequently detected in the lungs of patients with severe influenza than bacterial pathogens. Detection of bacterial pathogens associates with worse outcome in patients with influenza, particularly in those with IAPA, but not in patients with COVID-19. The immunological dynamics of tripartite viral-fungal-bacterial interactions deserve further investigation.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Feys S, Cardinali-Benigni M, Lauwers HM, et al. Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis. Am J Respir Crit Care Med. 2024. PMID: 38865563. doi:10.1164/rccm.202401-0145OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。